117 Aufrufe 117 0 Kommentare 0 Kommentare

    Inotiv, Inc. to Participate in Three Investor Conferences in September 2025

    WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the upcoming H.C. Wainwright 27th Annual Global Investment Conference, the Baird Global Healthcare Conference and the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference.

    Conference Details

    Event: Baird Global Healthcare Conference
    Location: New York, NY
    Date and Presentation Time: 12:50 PM Eastern Time on September 9, 2025
    Event Format: Presentations and 1-on-1 meetings
    Link to Webcast

    Event: H.C. Wainwright 27th Annual Global Investment Conference
    Location: New York, NY
    Date and Presentation Time: 12:30 PM Eastern Time on September 10, 2025
    Event Format: Presentations and 1-on-1 meetings
    Link to Webcast

    Event: Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
    Location: New York, NY
    Date: September 11, 2025
    Event format: 1-on-1 institutional investor meetings only

    To schedule a meeting at the conferences with Inotiv management or for more conference information, please contact your institutional sales representative at each firm.

    About Inotiv

    Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical research and development projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.

    Seite 1 von 3 




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Inotiv, Inc. to Participate in Three Investor Conferences in September 2025 WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) - Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and …